Literature DB >> 10358155

p38 alpha mitogen-activated protein kinase is activated by CD28-mediated signaling and is required for IL-4 production by human CD4+CD45RO+ T cells and Th2 effector cells.

P H Schafer1, S A Wadsworth, L Wang, J J Siekierka.   

Abstract

T cell proliferation and cytokine production usually require stimulation via both the TCR/CD3 complex and the CD28 costimulatory receptor. Using purified human CD4+ peripheral blood T cells, we show that CD28 stimulation alone activates p38 alpha mitogen-activated protein kinase (p38 alpha). Cell proliferation induced by CD28 stimulation alone, a response attributed to CD4+CD45RO+ memory T cells, was blocked by the highly specific p38 inhibitors SB 203580 (IC50 = 10-80 nM) and RWJ 67657 (IC50 = 0.5-4 nM). In contrast, proliferation induced by anti-CD3 plus anti-CD28 mAbs was not blocked. Inhibitors of p38 also blocked CD4+ T cell production of IL-4 (SB 203580 IC50 = 20-100 nM), but not IL-2, in response to CD3 and CD28 stimulation. IL-5, TNF-alpha, and IFN-gamma production were also inhibited, but to a lesser degree than IL-4. IL-4 production was attributed to CD4+CD45RO+ T cells, and its induction was suppressed by p38 inhibitors at the mRNA level. In polarized Th1 and Th2 cell lines, SB 203580 strongly inhibited IL-4 production by Th2 cells (IC50 = 10-80 nM), but only partially inhibited IFN-gamma and IL-2 production by Th1 cells (<50% inhibition at 1 microM). In both Th1 and Th2 cells, CD28 signaling activated p38 alpha and was required for cytokine production. These results show that p38 alpha plays an important role in some, but not all, CD28-dependent cellular responses. Its preferential involvement in IL-4 production by CD4+CD45RO+ T cells and Th2 effector cells suggests that p38 alpha may be important in the generation of Th2-type responses in humans.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10358155

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  20 in total

Review 1.  Mechanisms of immune resolution.

Authors:  Alfred Ayala; Chun-Shiang Chung; Patricia S Grutkoski; Grace Y Song
Journal:  Crit Care Med       Date:  2003-08       Impact factor: 7.598

Review 2.  The emerging role of p38 mitogen-activated protein kinase in multiple sclerosis and its models.

Authors:  Dimitry N Krementsov; Tina M Thornton; Cory Teuscher; Mercedes Rincon
Journal:  Mol Cell Biol       Date:  2013-07-29       Impact factor: 4.272

3.  Selective expansion of memory CD4(+) T cells by mitogenic human CD28 generates inflammatory cytokines and regulatory T cells.

Authors:  Manisha Singh; Sreemanti Basu; Christina Camell; Jacob Couturier; Rodolfo J Nudelman; Miguel A Medina; John R Rodgers; Dorothy E Lewis
Journal:  Eur J Immunol       Date:  2008-06       Impact factor: 5.532

4.  Opposing roles of serine/threonine kinases MEKK1 and LOK in regulating the CD28 responsive element in T-cells.

Authors:  Li Tao; Scott Wadsworth; Jason Mercer; Cynthia Mueller; Kirsten Lynn; John Siekierka; Avery August
Journal:  Biochem J       Date:  2002-04-01       Impact factor: 3.857

5.  PATHOLOGICAL ASPECTS OF THE ANTI-INFLAMMATORY/IMMUNE SUPPRESSIVE RESPONSE IN SEPSIS AND SHOCK.

Authors:  Alfred Ayala; Yanli Ding; Rebecca J Rhee; Lesley A Doughty; Patrician S Grutkoski; Chun-Shiang Chung
Journal:  Rec Res Dev Immunol       Date:  2003-01-12

6.  Regulation of IL-13 synthesis in human lymphocytes: implications for asthma therapy.

Authors:  Andreas Pahl; Meixia Zhang; Hildegard Kuss; Istvan Szelenyi; Kay Brune
Journal:  Br J Pharmacol       Date:  2002-04       Impact factor: 8.739

7.  Formononetin, a phyto-oestrogen, and its metabolites up-regulate interleukin-4 production in activated T cells via increased AP-1 DNA binding activity.

Authors:  Jin Park; Seung H Kim; Daeho Cho; Tae S Kim
Journal:  Immunology       Date:  2005-09       Impact factor: 7.397

Review 8.  ROCKs as immunomodulators of stroke.

Authors:  Qing Mei Wang; James K Liao
Journal:  Expert Opin Ther Targets       Date:  2012-08-27       Impact factor: 6.902

9.  SPAK kinase is a substrate and target of PKCtheta in T-cell receptor-induced AP-1 activation pathway.

Authors:  Yingqiu Li; Junru Hu; Randi Vita; Binggang Sun; Hiroki Tabata; Amnon Altman
Journal:  EMBO J       Date:  2004-02-26       Impact factor: 11.598

10.  Restoration of corticosteroid sensitivity by p38 mitogen activated protein kinase inhibition in peripheral blood mononuclear cells from severe asthma.

Authors:  Nicolas Mercado; Amir Hakim; Yoshiki Kobayashi; Sally Meah; Omar S Usmani; Kian Fan Chung; Peter J Barnes; Kazuhiro Ito
Journal:  PLoS One       Date:  2012-07-23       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.